CAMBRIDGE, Mass.--(BUSINESS WIRE)--SAGE Therapeutics (SAGE), a biopharmaceutical company developing novel medicines to treat life-threatening, rare central nervous system (CNS) disorders, today ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sage Therapeutics, Inc. (Nasdaq: SAGE), today announced plans to reorganize its business operations and pipeline priorities to support goals for long-term business ...

The MarketWatch News Department was not involved in the creation of this content. Ormat Technologies and Carbon Direct Capital co-lead Series B financing, which will support the development of Sage's ...

Sage Therapeutics cut more than half of its workforce in a restructuring move that slams postpartum drug Zulresso and the sales team promoting it. The estimated 340 employees laid off primarily worked ...

Sage marked its centennial this year, commemorating a century of real estate in New York City. Founded in 1924, the company has been guided for four generations by a commitment to quality, integrity, ...

DALLAS, November 20, 2025--(BUSINESS WIRE)--Trinity Hunt Partners, a growth-oriented private equity firm, is pleased to announce the establishment of its commercial paving services platform under the ...

Strengthened financial position with expected annualized net savings of approximately $240 million anticipated to extend cash runway into 2026 CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, ...